Package

- Sanofi
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front top perspective view of first embodiment of a package showing our new design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a bottom view thereof;

FIG. 4 is a right side elevation view thereof;

FIG. 5 is a left side elevation view thereof;

FIG. 6 is a rear elevation view thereof;

FIG. 7 is a front elevation view thereof;

FIG. 8 is a front top perspective view of second embodiment of a package showing our new design;

FIG. 9 is a top plan view thereof;

FIG. 10 is a bottom view thereof;

FIG. 11 is a right side elevation view thereof;

FIG. 12 is a left side elevation view thereof;

FIG. 13 is a rear elevation view thereof; and,

FIG. 14 is a front elevation view thereof.

Claims

The ornamental design for a package, as shown and described.

Referenced Cited
U.S. Patent Documents
D87781 September 1932 Hauck
D98468 February 1936 Wandel
D323618 February 4, 1992 Arai
D362620 September 26, 1995 Nagasaka
D364346 November 21, 1995 Yamada
D364805 December 5, 1995 Hata
D366415 January 23, 1996 Nagasaka
D391481 March 3, 1998 Oxley
D396806 August 11, 1998 Burke
D419443 January 25, 2000 Yonehara
D719032 December 9, 2014 Kanda
D719462 December 16, 2014 Kanda
Other references
  • Sanofi and Regeneron Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients. [online] Published Jul. 24, 2015. Retrieved from URL: <http://www.multivu.com/players/English/7500451-sanofi-praluent-fda-approval/>.
Patent History
Patent number: D764289
Type: Grant
Filed: May 12, 2015
Date of Patent: Aug 23, 2016
Assignee: Sanofi (Paris)
Inventors: Claudia Hauck (Paris), Helene Capgras (Paris), Noriko Hattori (Tokyo), Cristina Fernandez (Paris)
Primary Examiner: Vy Koenig
Application Number: 29/526,612
Classifications
Current U.S. Class: D9/432